BriaCell Reports Sustained Complete Resolution of Lung Metastasis in Bria-OTS(TM) Patient
On Jan. 13, 2026, BriaCell Therapeutics announces the durable and sustained complete resolution of a lung metastasis in…
-
-
Stem cell engineering breakthrough paves way for next-generation living drugs
On Jan. 8, 2026, for the first time, researchers at the University of British Columbia have demonstrated how…
-
First human transplant of kidney modified to have ‘universal’ blood type
On Oct. 3, 2025, scientists have converted the blood type of a donor kidney and transplanted the organ…
-
UBC Faculty of Medicine members receive 2023 Order of British Columbia
On Jun. 5, 2023, the University of British Columbia (UBC) announced that the faculty of medicine’s Drs. John…
-
Rapid bedside test predicts sepsis with over 90 percent accuracy
On May 27, 2025, Canadian scientists announced they have developed a blood test and portable device that can…
-
What’s a healthy amount of sleep? It differs from one country to another
On May 8, 2025, University of British Columbia (UBC) research has found that your optimal amount of sleep…
-
Passenger with measles travelled through Vancouver International Airport
On Oct. 29, 2024, the BC Centre for Disease Control announced that travellers were alerted to potential exposure…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
Alpha Cognition’s Oral Therapy ZUNVEYL® Receives FDA Approval to Treat Alzheimer’s Disease
On Jul. 29, 2024, announces that the U.S. Food and Drug Administration (FDA) has granted approval for ZUNVEYL®…
-
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…
-
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
Passenger with measles travelled through Vancouver International Airport
On Nov. 29, 2023, the BC Centre for Disease Controlr Disease Control (BCCDC) announced that a A passenger…
-
Biological fingerprints in soil showed where diamond-containing ore is buried
On Oct. 25, 2023, University of British Columbia researchers announced they had identified buried kimberlite, the rocky home…
-
Biotechnology | Diagnostics | Disease | Medical Device | Nanotechnology | Non-Profit Research | Therapeutics
British Columbia Institute of Technology received $14.5 million to support aerospace and life sciences training
On Feb. 14, 2023, the Pacific Economic Development Agency of Canada (PacifiCan), announced $14.5 million in funding for…
-
Biotechnology | Diagnostics | Disease | Medical Device | Medicine | Non-Profit Research | Therapeutics
University of Victoria BioInnovation Hub to enhance collaboration in BC’s life sciences sector
On Aug. 31, 2022, a new front-door to the University of Victoria opened to advance health and life…
-
British Columbia Officials confirm highly pathogenic avian influenza in the Pacific Flyway
On Mar. 2, 2022, British Columbia officials announced it is working to prevent highly pathogenic avian influenza from infecting…
-
University of British Columbia researchers received the New Frontiers in Research Fund 2020 Exploration award
On Jun. 14, 2021, University of British Columbia researchers Dr. Jayachandran Kizhakkedathu, Dr. Caigan Du and Dr. Christopher…
-
APEIRON Biologics’ APN01 selected for large-scale U.S. trial in COVID-19
On May 19, 2021, APEIRON Biologics announced the next development steps for APN01 (alunacedase alfa) for the treatment…
-
The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
-
Dr. Connie Eaves was inducted into The Royal Society for her development of robust functional methods to quantify and characterize distinct types of primitive blood and mammary cell precursors.
On May 11, 2011, University of British Columbia professor Connie Eaves was inducted into The Royal Society for…
-
University of British Columbia researchers unveiled first molecular images of B.1.1.7 COVID-19 mutation
On May 3, 2021, University of British Columbia (UBC) researchers were the first in the world to publish…
-
XPhyto announces European approval for 25 minute COVID-19 PCR test
On Mar. 18, 2021, XPhyto and its exclusive German diagnostics development partner, 3a-diagnostics, are pleased to announce the…
-
XPhyto partner received ISO Certification for 25-minute COVID-19 RT-PCR test
On Mar. 10, 2021, XPhyto and 3a-diagnostics announced successful EN ISO 13485 certification for the rapid point-of-care, SARS-CoV-2…
-
Biotechnology | Cardiology | Disease | FDA | Therapeutics
FDA approved Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for adults with active lupus nephritis
On Jan. 22, 2021, Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved LUPKYNISTM…
-
Peanut allergy treatment significantly lowered risk of life-threatening reactions in preschoolers
On Dec. 3, 2020, a new study by researchers at the University of British Columbia and BC Children’s…
-
Biotechnology | COVID-19 | Diagnostics | Genomics | Infectious Disease | Non-Profit Research | Vaccine
University of British Columbia scientists sequence genomes of Canadians with COVID-19
On Jul. 22, 2020, through the Canadian COVID Genomics Network (CanCOGeN) ‘a new initiative was launched by Genome…
-
Pascal Biosciences discovered a cannabinoid that combats Coronavirus
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
-
Government of Canada and provincial partners invested more than $109 mllion in COVID-19 research
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Non-Profit Research | Therapeutics | Vaccine
University of British Columbia received $14 million in federal funding for COVID-19 research
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
-
University of British Columbia researchers developed biodegradable medical mask for COVID-19
On May 21, 2020, the BioProducts Institute at the University of British Columbia announced it had designed a…
-
University of British Columbia scientist identified a gene that controls thinness
On May 21, 2020, in a study published in the journal Cell, Life Sciences Institute Director Dr. Josef…
